EP Patent

EP0005636A1 — Method and product for inducing anorexia

Assigned to EIDP Inc · Expires 1979-11-28 · 46y expired

What this patent protects

Naltrexone or a pharmaceutically effective salt thereof is administered orally so as to effect appetite suppression in mammals.

USPTO Abstract

Naltrexone or a pharmaceutically effective salt thereof is administered orally so as to effect appetite suppression in mammals.

Drugs covered by this patent

Patent Metadata

Patent number: EP0005636A1
Jurisdiction: EP
Classification: —
Expires: 1979-11-28
Drug substance claim: No
Drug product claim: No
Assignee: EIDP Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.